Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas V Faller

Showing results (51-60 of 126) with videos related to

Pageof 13
Sort By:
Clinical Journal of Oncology Nursing|August 8, 2022
Understanding Amyloidosis: Unraveling the Complexities and Therapeutic Approaches for Oncology NursesTeresa Fogaren, Anthony C Shelton, Douglas V Faller, et al.
Journal of Clinical Pharmacology|August 26, 2021
Population Pharmacokinetics and Exposure-Safety Relationships of Alisertib in Children and Adolescents With Advanced MalignanciesXiaofei Zhou, Diane R Mould, Ying Yuan, et al.
Molecular Cancer Research : MCR|August 22, 2014
SIRT1 inactivation evokes antitumor activities in NSCLC through the tumor suppressor p27Lijia Zhu, Christine Y Chiao, Katelyn G Enzer, et al.
ACS Chemical Biology|February 11, 2014
Protein kinase Cδ is a therapeutic target in malignant melanoma with NRAS mutationAsami Takashima, Brandon English, Zhihong Chen, et al.
Clinical Lung Cancer|June 15, 2022
Survival Outcomes and Treatment Patterns in Patients With NFE2L2 and/or KEAP1 Mutation-Positive Advanced Squamous Cell NSCLC Using a Real-World Clinico-Genomic DatabaseYanyu Wu, Yu Yin, Victoria Crossland, et al.
Virology|November 18, 2005
Leukemia virus long terminal repeat activates NFkappaB pathway by a TLR3-dependent mechanismAna L Abujamra, Remco A Spanjaard, Idowu Akinsheye, et al.
Anticancer Research|August 27, 2011
Histone deacetylase inhibitors reverse CpG methylation by regulating DNMT1 through ERK signalingSibaji Sarkar, Ana L Abujamra, Jenny E Loew, et al.
International Journal of Biological Sciences|October 14, 2010
Aberrant cytoplasm localization and protein stability of SIRT1 is regulated by PI3K/IGF-1R signaling in human cancer cellsVanessa Byles, Laura K Chmilewski, Joyce Wang, et al.
Journal of Proteome Research|March 4, 2006
Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machinesGerald V Denis, Mark E McComb, Douglas V Faller, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 27, 2018
Effectiveness and Safety of Therapeutic Regimens for Elderly Patients With Acute Myeloid Leukemia: A Systematic Literature ReviewJill A Bell, Aaron Galaznik, Rachel Huelin, et al.
Pageof 13

Showing results (51-60 of 126) with videos related to

Sort By:
Pageof 13
Clinical Journal of Oncology Nursing|August 8, 2022
Understanding Amyloidosis: Unraveling the Complexities and Therapeutic Approaches for Oncology NursesTeresa Fogaren, Anthony C Shelton, Douglas V Faller, et al.
Journal of Clinical Pharmacology|August 26, 2021
Population Pharmacokinetics and Exposure-Safety Relationships of Alisertib in Children and Adolescents With Advanced MalignanciesXiaofei Zhou, Diane R Mould, Ying Yuan, et al.
Molecular Cancer Research : MCR|August 22, 2014
SIRT1 inactivation evokes antitumor activities in NSCLC through the tumor suppressor p27Lijia Zhu, Christine Y Chiao, Katelyn G Enzer, et al.
ACS Chemical Biology|February 11, 2014
Protein kinase Cδ is a therapeutic target in malignant melanoma with NRAS mutationAsami Takashima, Brandon English, Zhihong Chen, et al.
Clinical Lung Cancer|June 15, 2022
Survival Outcomes and Treatment Patterns in Patients With NFE2L2 and/or KEAP1 Mutation-Positive Advanced Squamous Cell NSCLC Using a Real-World Clinico-Genomic DatabaseYanyu Wu, Yu Yin, Victoria Crossland, et al.
Virology|November 18, 2005
Leukemia virus long terminal repeat activates NFkappaB pathway by a TLR3-dependent mechanismAna L Abujamra, Remco A Spanjaard, Idowu Akinsheye, et al.
Anticancer Research|August 27, 2011
Histone deacetylase inhibitors reverse CpG methylation by regulating DNMT1 through ERK signalingSibaji Sarkar, Ana L Abujamra, Jenny E Loew, et al.
International Journal of Biological Sciences|October 14, 2010
Aberrant cytoplasm localization and protein stability of SIRT1 is regulated by PI3K/IGF-1R signaling in human cancer cellsVanessa Byles, Laura K Chmilewski, Joyce Wang, et al.
Journal of Proteome Research|March 4, 2006
Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machinesGerald V Denis, Mark E McComb, Douglas V Faller, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 27, 2018
Effectiveness and Safety of Therapeutic Regimens for Elderly Patients With Acute Myeloid Leukemia: A Systematic Literature ReviewJill A Bell, Aaron Galaznik, Rachel Huelin, et al.
Pageof 13